Hims & Hers Health, Inc.
forhims.comWhat Do They Do?
Connects consumers with licensed clinicians online and offers prescription and non-prescription health products and care for a range of conditions.
10-K for FY2025, filed Feb 23, 2026
How Do They Make Money?
Individuals buy prescription and non-prescription products and services on the company’s websites and apps; subscription customers are billed repeatedly as product shipments are sent, while one-time purchases are also available. Retailers buy non-prescription products through wholesale agreements.
10-K for FY2025, filed Feb 23, 2026“Online Revenue” represents the sales of products and services on our platform, net of refunds, credits, and chargebacks, and includes…View ↗
“Wholesale Revenue” represents non-prescription product sales to retailers through wholesale purchasing agreements. Wholesale Revenue also…View ↗
For subscription plans, in addition to a 30-day cadence or treatment term, we offer customers the ability to select from a range of…View ↗
$2.3B
-
10-K for FY2025, filed Feb 23, 2026
$2.3B ↗
Who Are Their Customers?
Individuals buy mainly through the company’s websites and mobile apps. Retailers buy non-prescription products through wholesale agreements, and some products are sold in retail stores and online.
10-K for FY2025, filed Feb 23, 2026For both United States Revenue and Rest of the World Revenue, a significant majority of customers are individuals who purchase products…View ↗
In addition, we offer access to a range of health and wellness products designed to meet individual needs, which can include curated…View ↗
“Online Revenue” represents the sales of products and services on our platform, net of refunds, credits, and chargebacks, and includes…View ↗
“Wholesale Revenue” represents non-prescription product sales to retailers through wholesale purchasing agreements. Wholesale Revenue also…View ↗
Do Revenues Turn Into Profits?
Yes. It kept 5 cents of every revenue dollar as net income in FY2025 and turned 2 cents into free cash flow.
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 10, 2026
−$86.3MView ↗
- ▼ Now a loss
- vs $42.5M in Q2 FY2025
-
Aug 10, 2026
Raised full-year revenue guidance
Now expects FY2026 revenue of $3.1 billion to $3.3 billion.
Sources
8-K, filed Aug 10, 2026
Raises full year 2026 revenue guidance to a range of $3.1 billion to $3.3 billion and updates Adjusted EBITDA guidance to a range of $275…View ↗
-
Jun 2, 2026
Completed its acquisition of Eucalyptus
The acquisition expands its operations into Australia and Japan and deepens its presence in other markets.
Sources
8-K, filed Jun 2, 2026
On June 2, 2026, the Company issued a press release announcing the completion of its previously announced acquisition of Eucalyptus. A copy…View ↗
-
Mar 11, 2026
Shifted U.S. weight-loss offering toward FDA-approved GLP-1 medicines
Plans to offer a broader range of approved medicines and provide compounded semaglutide on a limited scale.
Sources
8-K, filed Mar 11, 2026
SAN FRANCISCO, March 9, 2026 – Hims & Hers Health, Inc. (NYSE: HIMS) today announced a collaboration with Novo Nordisk as part of a new…View ↗
Growing. Revenue grew 8.6x in 4 years, from $271.9M in FY2021 to $2.3B in FY2025, about 71% a year.
Specialty offerings
The older report described testosterone and menopause as future care opportunities; the latest report says the company launched offerings in those areas.
10-K for FY2022, filed Feb 27, 2023 10-K for FY2025, filed Feb 23, 2026We are pursuing a roadmap of rapid category expansion into new conditions that can be treated safely via telehealth, require ongoing and…View ↗
We are pursuing a roadmap of rapid specialty expansion into new conditions that can be appropriately addressed via telehealth, require…View ↗
Loading...
